International Stem Cell Corp. (ISCO) Investors Increase Stake in Company
International Stem Cell Corp., a California-based biotechnology company focused on the therapeutic applications of human parthenogenetic stem cells, announced today that $1 million has been invested by a number of existing long-standing investors through a private placement on the same terms as the transaction with management reported on January 22, 2013. The funds, along with those received in January 2013 from members of the management team, will help advance ISCO’s therapeutic programs towards clinical stage, building upon recently announced promising pre-clinical data for both the Parkinson's and Liver disease programs. "To have a number of existing shareholders increase their positions…